|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.5
|
37368200
|
Legaz I, Navarro-Noguera E, Collados-Ros A, Bolarin JM, Muro M. Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis. Biomedicines. 2024 Feb 1;12(2):336. doi: 10.3390/biomedicines12020336. PubMed PMID: 38397937; PubMed Central PMCID: PMC10887413.
AÑO: 2024; IF: 3.9
|
|
Moya-Quiles MR, Muro M. Identification of three new HLA-A intronic variants by next-generation sequencing. HLA. 2024 Oct;104(4):e15708. doi: 10.1111/tan.15708. PubMed PMID: 39352206.
AÑO: 2024; IF: 4.1
|
|
Pons-Fuster E, Bernal E, Guillamon CF, Gimeno L, Martinez-Sanchez MV, Ruiz-Lorente I, Campillo JA, Ceballos D, Torres A, Tomas C, Munoz A, Alcaraz A, Selma P, Ruiz-Nicolas C, Muro M, Minguela A. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation. Infect Dis (Lond). 2024 Oct;56(10):818-829. doi: 10.1080/23744235.2024.2351047. Epub 2024 May 14. PubMed PMID: 38743055.
AÑO: 2024; IF: 2.3
|
|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ruiz-Lorente I, Ceballos-Francisco D, Muro M, Martinez-Camblor P, Minguela A. Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases. Biomedicines. 2024 Oct 24;12(11):2439. doi: 10.3390/biomedicines12112439. PubMed PMID: 39595006; PubMed Central PMCID: PMC11592343.
AÑO: 2024; IF: 3.9
|